Auron Therapeutics

Auron Therapeutics is a biotech company in Newton, United States. It has raised $87.8M across 3 rounds, most recently a $27.0M Series B in February 2025.

Focused Team. One Purpose.

Employees
11–50
Business Model
B2B
Total Funding
$87.8M
Last Round
$27.0M Series BFeb 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 12 investors for this company. The full record is or through the API.

About

Auron Therapeutics is a patient-centered, platform-powered oncology company developing therapies that target cell-state plasticity — the root driver of cancer and inflammatory disease. Its proprietary AURIGIN platform uses AI and single-cell genomics to identify novel drug targets. Lead program AUTX-703 is in clinical development for AML and other hematologic malignancies.

Summary

It lists 11–50 employees. It has raised $87.8M in total across 3 rounds, most recently a $27.0M Series B round in Feb 2025. Investors include Polaris Partners, DCVC (Data Collab) and Arkin Bio Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series BSeries BFeb 2025
$27.0M

Sign up to see all 3 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Auron Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/auron-therapeutics"><img src="https://indexed.vc/api/badge/company/auron-therapeutics" alt="Auron Therapeutics on Indexed.vc" width="260" height="76" /></a>